Mitochondrial Contribution to Parkinson's Disease Pathogenesis
The identification of the etiologies and pathogenesis of Parkinson's disease (PD) should play an important role in enabling the development of novel treatment strategies to prevent or slow the progression of the disease. The last few years have seen enormous progress in this respect. Abnormalit...
Saved in:
| Main Authors: | Anthony H. V. Schapira, Matthew Gegg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Parkinson's Disease |
| Online Access: | http://dx.doi.org/10.4061/2011/159160 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioenergetic consequences of PINK1 mutations in Parkinson disease.
by: Andrey Yurevich Abramov, et al.
Published: (2011-01-01) -
Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells.
by: Matthew E Gegg, et al.
Published: (2009-01-01) -
Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
by: Ross B. Mounsey, et al.
Published: (2011-01-01) -
Mitochondrial Dysfunction in the Pathogenesis of Parkinson Disease: Current Concepts and Potential Therapeutic Strategies
by: Natalia G. Zhukova, et al.
Published: (2025-06-01) -
Genetic Mutations and Mitochondrial Toxins Shed New Light on the Pathogenesis of Parkinson's Disease
by: Shigeto Sato, et al.
Published: (2011-01-01)